| Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and d‐dimer elevation in Thai people after ChAdOx1 nCoV‐19 vaccination N Uaprasert, P Watanaboonyongcharoen, R Vichitratchaneekorn, ... Research and Practice in Thrombosis and Haemostasis 5 (6), e12580, 2021 | 15 | 2021 |
| Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies N Uaprasert, S Trithiphen, A Sukperm, B Akkawat, ... Research and practice in thrombosis and haemostasis 5 (8), 2021 | 3 | 2021 |
| Prevalence of long QT interval in Thailand and its association with all cause and cardiovascular mortality from a long-term cohort study S Trithiphen, P Vatesatogkit, T Ngarmukos, P Chandanamattha, ... Eur Heart J 40, 4177, 2019 | 2 | 2019 |
| Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations C Polprasert, P Niparuck, T Rattanathammethee, S Chuncharunee, ... Clinical Lymphoma Myeloma and Leukemia 22 (5), e293-e299, 2022 | 1 | 2022 |
| LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS) WITHOUT MUTATIONS ARE AS GOOD AS IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS) C Polprasert, P Niparuck, T Rattanathammethee, S Chuncharunee, ... LEUKEMIA RESEARCH 108, S14-S14, 2021 | | 2021 |
| Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS) WITHOUT MUTATIONS ARE AS GOOD AS IDIOPATHIC CYTOPENIA OF UNDETERMINED … C Polprasert, P Niparuck, T Rattanathammethee, S Chuncharunee, ... Leukemia Research 108, 106680.4, 2021 | | 2021 |
